Rational Combinations of Targeted Agents in AML

By Bose Prithviraj   Grant Steven  

Journal of Clinical Medicine, Vol. 4, Iss. 4, 2015-04 ,pp. : 634-664

MDPI

Access to resources Recommend Favorite

Pediatric AML: From Biology to Clinical Management

By de Rooij Jasmijn D. E.   Zwaan C. Michel   van den Heuvel-Eibrink Marry  

Journal of Clinical Medicine, Vol. 4, Iss. 1, 2015-01 ,pp. : 127-149

MDPI

Access to resources Recommend Favorite

Immunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment

By Gbolahan Olumide Babajide   Zeidan Amer M.   Stahl Maximilian   Abu Zaid Mohammad   Farag Sherif   Paczesny Sophie   Konig Heiko  

International Journal of Molecular Sciences, Vol. 18, Iss. 8, 2017-07 ,pp. : 1660-1660

MDPI

Access to resources Recommend Favorite

The Development of Novel Therapies for the Treatment of Acute Myeloid Leukemia (AML)

By Assouline Sarit   Cocolakis Eftihia   Borden Katherine L. B.  

Cancers, Vol. 4, Iss. 4, 2012-11 ,pp. : 1161-1179

MDPI

Access to resources Recommend Favorite

Targeted Therapy of FLT3 in Treatment of AML—Current Status and Future Directions

By Engen Caroline Benedicte Nitter   Wergeland Line   Skavland Jørn   Gjertsen Bjørn Tore  

Journal of Clinical Medicine, Vol. 3, Iss. 4, 2014-12 ,pp. : 1466-1489

MDPI

Access to resources Recommend Favorite